Found: 23
Select item for more details and to access through your institution.
Treatment with low‐dose, single‐agent belantamab mafodotin is safe and provides long‐term responses in heavily pretreated multiple myeloma patients.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 3, p. 367, doi. 10.1111/ejh.14120
- By:
- Publication type:
- Article
Management and outcome of 500 multiple myeloma patients treated for first relapse outside clinical studies.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 11, p. 3075, doi. 10.1007/s00277-023-05307-1
- By:
- Publication type:
- Article
REGEN‐COV antibody combination in patients with lymphoproliferative malignancies and SARS‐CoV‐2 infection.
- Published in:
- EJHaem, 2022, v. 3, n. 2, p. 471, doi. 10.1002/jha2.403
- By:
- Publication type:
- Article
Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myeloma.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 2, p. 186, doi. 10.1111/bjh.17608
- By:
- Publication type:
- Article
Correlation between BNT162b2 mRNA Covid-19 vaccine-associated hypermetabolic lymphadenopathy and humoral immunity in patients with hematologic malignancy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 11, p. 3540, doi. 10.1007/s00259-021-05389-x
- By:
- Publication type:
- Article
Lower Patient Anxiety and Unchanged Levels of Adherence to Hemato-Oncologic Treatment in Response to New Measures to Reduce Hospital Exposure Risk to COVID-19.
- Published in:
- Patient Preference & Adherence, 2021, v. 15, p. 945, doi. 10.2147/PPA.S307561
- By:
- Publication type:
- Article
Daratumumab for relapsed AL amyloidosis—When cumulative real‐world data precedes clinical trials: A multisite study and systematic literature review.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 2, p. 184, doi. 10.1111/ejh.13535
- By:
- Publication type:
- Article
Daratumumab With Cetrelimab, an Anti-PD-1 Monoclonal Antibody, in Relapsed/Refractory Multiple Myeloma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Bortezomib Maintenance Therapy as a Standard of Care Provides Favorable Outcomes in Newly Diagnosed Myeloma Patients: A Multisite Real-Life Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Bortezomib washout duration prior to stem cell mobilization in patients with newly diagnosed multiple myeloma.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 1, p. 30, doi. 10.1111/ejh.13404
- By:
- Publication type:
- Article
Clinical characteristics and outcomes of oligosecretory and non-secretory multiple myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Real‐world data on incidence, clinical characteristics and outcome of patients with macrofocal multiple myeloma (MFMM) in the era of novel therapies: A study of the Greco‐Israeli collaborative myeloma working group.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 5, p. 465, doi. 10.1002/ajh.25755
- By:
- Publication type:
- Article
Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 694, doi. 10.1093/neuonc/noz231
- By:
- Publication type:
- Article
A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE).
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 705, doi. 10.1093/neuonc/noz232
- By:
- Publication type:
- Article
Hematogenous extramedullary relapse in multiple myeloma ‐ a multicenter retrospective study in 127 patients.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 10, p. 1132, doi. 10.1002/ajh.25579
- By:
- Publication type:
- Article
ATIM-19. RESULTS OF THE GLOBE STUDY: A PHASE 3, RANDOMIZED, CONTROLLED, DOUBLE-ARM, OPEN-LABEL, MULTI-CENTER STUDY OF VB-111 COMBINED WITH BEVACIZUMAB VS. BEVACIZUMAB MONOTHERAPY IN PATIENTS WITH RECURRENT GLIOBLASTOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi4, doi. 10.1093/neuonc/noy148.014
- By:
- Publication type:
- Article
Treatment patterns and clinical outcomes in high‐risk newly diagnosed multiple myeloma patients carrying the 17p deletion: An observational multi‐center retrospective study.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 6, p. 810, doi. 10.1002/ajh.25098
- By:
- Publication type:
- Article
Serum free immunoglobulin light chain fingerprint identifies a subset of newly diagnosed multiple myeloma patients with worse outcome.
- Published in:
- 2017
- By:
- Publication type:
- journal article
<sup>18</sup>F-FDG-PET/CT Pulmonary Infiltrates in non-Hodgkin's lymphoma Patients Treated with Combined Immunochemotherapy: Incidence and Clinical Characteristics.
- Published in:
- Israel Medical Association Journal, 2017, v. 19, n. 6, p. 372
- By:
- Publication type:
- Article
Efficacy and safety of autologous hematopoietic cell transplantation in elderly patients with multiple myeloma: a retrospective national multi-site cohort study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy and safety of salvage therapy using Carfilzomib for relapsed or refractory multiple myeloma patients: a multicentre retrospective observational study.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 1, p. 89, doi. 10.1111/bjh.13799
- By:
- Publication type:
- Article
Detection Bias Due to the Effect of Finasteride on Prostate Volume: A Modeling Approach for Analysis of the Prostate Cancer Prevention Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 18, p. 1366, doi. 10.1093/jnci/djm130
- By:
- Publication type:
- Article